According to the American Lung Association, biomarker testing gaps and low screening rates continue to hinder lung cancer ...
Cape Cod Healthcare will participate in a new national clinical research study focused on early detection of lung cancer with ...
The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
Rhode Island ranked second for its lung cancer survival rate, with more than 35% living five years post diagnosis. The state ...
The primary endpoint of overall survival was missed in the SKYSCRAPER-01 study assessing tiragolumab plus Tecentriq in some ...
AstraZeneca's Imfinzi gains FDA Priority Review for bladder cancer. Key trial data shows improved survival and progression ...
The Tampa Bay Times e-Newspaper is a digital replica of the printed paper seven days a week that is available to read on ...
AstraZeneca and Daiichi Sankyo have shared the data they believe can secure approval for datopotamab deruxtecan (Dato-DXd) at ...
Dr. Heba Ismail at Sutter Health’s California Pacific Medical Center has dedicated her career to the early detection and ...
The "Lung Cancer Therapeutics - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The ...
FDA approves AstraZeneca’s Imfinzi for limited-stage small cell lung cancer, cutting the risk of death by 27% in the ADRIATIC ...